Us Bancorp \De\ Agios Pharmaceuticals, Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 221 shares of AGIO stock, worth $12,305. This represents 0.0% of its overall portfolio holdings.

Number of Shares

221

Previous 153 44.44%

Holding current value

$12,305

Previous $6,000 50.0%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$41.19 - $49.72 $2,800 - $3,380	68 Added 44.44%	221 $9,000
Q2 2024 Aug 06, 2024	SELL	$27.55 - $48.83 $2,093 - $3,711	-76 Reduced 33.19%	153 $6,000
Q1 2024 May 07, 2024	SELL	$21.32 - $34.81 $18,740 - $30,597	-879 Reduced 79.33%	229 $6,000
Q4 2023 Feb 09, 2024	SELL	$19.97 - $24.53 $4,952 - $6,083	-248 Reduced 18.29%	1,108 $24,000
Q3 2023 Nov 03, 2023	SELL	$24.36 - $28.18 $55,394 - $64,081	-2,274 Reduced 62.64%	1,356 $33,000
Q2 2023 Aug 09, 2023	SELL	$21.38 - $29.19 $3,014 - $4,115	-141 Reduced 3.74%	3,630 $102,000
Q1 2023 May 09, 2023	BUY	$21.74 - $30.93 $43 - $61	2 Added 0.05%	3,771 $86,000
Q4 2022 Feb 13, 2023	SELL	$24.81 - $31.52 $9,527 - $12,103	-384 Reduced 9.25%	3,769 $105,000
Q3 2022 Oct 27, 2022	BUY	$19.51 - $34.14 $3,121 - $5,462	160 Added 4.01%	4,153 $118,000
Q2 2022 Aug 01, 2022	BUY	$17.06 - $31.42 $62,780 - $115,625	3,680 Added 1175.72%	3,993 $88,000
Q1 2022 May 11, 2022	SELL	$26.68 - $34.81 $9,257 - $12,079	-347 Reduced 52.58%	313 $9,000
Q4 2021 Feb 11, 2022	SELL	$29.58 - $49.78 $31,561 - $53,115	-1,067 Reduced 61.78%	660 $22,000
Q3 2021 Nov 10, 2021	SELL	$41.92 - $58.18 $4,695 - $6,516	-112 Reduced 6.09%	1,727 $80,000
Q2 2021 Aug 05, 2021	BUY	$52.06 - $61.27 $728 - $857	14 Added 0.77%	1,839 $102,000
Q1 2021 Apr 28, 2021	SELL	$44.23 - $57.5 $130,390 - $169,510	-2,948 Reduced 61.76%	1,825 $93,000
Q4 2020 Feb 04, 2021	BUY	$33.21 - $46.54 $9,830 - $13,775	296 Added 6.61%	4,773 $207,000
Q3 2020 Nov 10, 2020	BUY	$33.87 - $55.93 $133,176 - $219,916	3,932 Added 721.47%	4,477 $157,000
Q2 2020 Aug 07, 2020	SELL	$34.45 - $53.48 $2,032 - $3,155	-59 Reduced 9.77%	545 $29,000
Q1 2020 May 13, 2020	SELL	$31.52 - $53.81 $25,940 - $44,285	-823 Reduced 57.67%	604 $21,000
Q4 2019 Feb 04, 2020	BUY	$30.08 - $50.59 $25,507 - $42,900	848 Added 146.46%	1,427 $67,000
Q3 2019 Nov 08, 2019	SELL	$32.4 - $49.58 $13,964 - $21,368	-431 Reduced 42.67%	579 $19,000
Q2 2019 Aug 13, 2019	BUY	$46.17 - $68.1 $21,099 - $31,121	457 Added 82.64%	1,010 $50,000
Q1 2019 May 08, 2019	SELL	$45.92 - $67.67 $2,755 - $4,060	-60 Reduced 9.79%	553 $37,000
Q4 2018 Feb 13, 2019	SELL	$42.73 - $76.53 $2,991 - $5,357	-70 Reduced 10.25%	613 $28,000
Q3 2018 Nov 01, 2018	BUY	$71.67 - $91.95 $1,935 - $2,482	27 Added 4.12%	683 $53,000
Q2 2018 Aug 08, 2018	BUY	$73.22 - $99.55 $39,758 - $54,055	543 Added 480.53%	656 $55,000
Q4 2017 Feb 02, 2018	SELL	$52.12 - $72.33 $886 - $1,229	-17 Reduced 13.08%	113 $6,000
Q3 2017 Nov 13, 2017	BUY	$54.89 - $67.12 $7,135 - $8,725	130	130 $9,000

Others Institutions Holding AGIO

# of Institutions

232

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.05B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account